# Intravenous Labetalol vs Phentolamine for the Management of Severe Preeclampsia.

> **NCT06385600** · NA · UNKNOWN · sponsor: **Assiut University** · enrollment: 200 (estimated)

## Conditions studied

- Severe Pre-eclampsia

## Interventions

- **DRUG:** Labetalol
- **DRUG:** Phentolamine

## Key facts

- **NCT ID:** NCT06385600
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-05-20
- **Primary completion:** 2026-01-20
- **Final completion:** 2026-03-20
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06385600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06385600, "Intravenous Labetalol vs Phentolamine for the Management of Severe Preeclampsia.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06385600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*